期刊文献+

大麻类物质与胃肠运动 被引量:1

Cannabinoid system and its role in the intestinal motility regulation
原文传递
导出
摘要 大麻类物质在临床的应用已有多年,但迄今为止对大麻素系统的作用机制,尤其对内源性大麻素系统参与胃肠运动调节的机制并不明了。本文介绍大麻类物质的种类,其受体、同类物、拮抗剂以及它们对胃肠运动的影响等,以望为大麻素类物质在临床的应用提供理论基础及实验依据,并为进一步开展对大麻素系统的探讨与研究提供近期的资料和信息。 Cannabinoids have been used in clinic for many years. However, their effective mechanisms, especially the role of the endogenous cannabinoid system in the regulation of intestinal motility are still poorly understood. In this article, we introduced that the compositions of the Cannabinoid family members, including their receptors, analogues, and antagonists, and the effects of them on the gastrointestinal movement. We provide the useful update information for the further clinic and experiment study on the cannabinoid family and the endocannabinoid system.
出处 《国际外科学杂志》 2008年第6期393-396,共4页 International Journal of Surgery
基金 国家自然科学基金资助项目(No.30570845)
关键词 大麻素 大麻素受体 内源性大麻素系统 肠管运动 cannabinoids cannabinoid receptor endogenous cannabinoid system intestinal motility
  • 相关文献

参考文献20

  • 1Pertwee RG. The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids[ J]. AAPS J, 2005, 7(3) :E625-654.
  • 2Matsuda LA, Lolait SJ, Brownstein MJ, et al. Structure of a cannabinoid receptor and a functional expression of the cloned cDNA [J]. Nature, 1990, 346(6284) :561-564.
  • 3Pertwee RG. Cannabinoids and the gastrointestinal tract[ J]. Gut, 2001,48(6) :859-867.
  • 4Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids [ J]. Nature, 1993, 365 (6441) :61-65.
  • 5Izzo AA, Fezza F, Capasso R, et al. Cannabinoid CBl-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation[J]. Br J Pharmacol, 2001, 134(3) :563- 570.
  • 6Wilson RI, Nicoll RA. Endocanabinoid signaling in the brain[J]. Science, 2002, 296(5568) :678-682.
  • 7Calignano A, La Rana G, Loubet-Lescouli P, et al. A role for the endogenous cannabinoid system in the peripheral control of pain initiation [ J ]. Prog Brain Res, 2000, 129 ( 1 ) :471-482.
  • 8Tsvetanova E, Kessiova M, Alexandrova A, et al. In vivo effects of CB1 receptor ligands on lipid peroxidation and antioxidant defense systems in the rat brain of healthy and ethanol-treated rats [ J ]. Pharmacol Rep, 2006, 58(6) :876-883.
  • 9Berm dez-Siva F J, Serrano A, Diaz-Molina FJ, et al. Activation of cannabinoid CB1 receptors induces glucose intolerance in rats[ J]. Eur J Pharmacol, 2006, 531 ( 1-3 ) :282-284.
  • 10Compton DR, Aceto MD, Lowe J, et al. In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A) :inhibition of A9-tetrahydrocannabinol-induced responsed and apparent agonist activity [ J ]. J Pharmacol Exp Ther, 1996, 277 ( 2 ) : 586 - 594.

同被引文献29

  • 1Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor[ J]. Sci- ence, 1992, 258(5090): 1946-1949.
  • 2Mechoulam R, Ben- Shabat S, Hanus L, et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors[ J]. Bioehem Pharmacol, 1995, 50 ( 1 ) : 83-90.
  • 3Porter AC, Saner JM, Knierman MD, et al. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB 1 receptor[JJ. Pharmaeol Exp Ther, 2002, 301 (3): 1020 - 1024.
  • 4Stoor MA, Yuce B, Andrews CN, et al. The role of the endocan- nabinoid system in the pathophysiology and treatment of irritable bowel syndrome [ J ]. Neurogastroenterol Motil, 2008, 20 ( 8 ) : 857-868.
  • 5Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for eannabinoids [ J]. Nature, 1993, 365 (6441) : 61-65.
  • 6Matsuda LA, Lolait SJ, Brownstein M J, et al. Structure of a can- nabinoid receptor and a functional expression of the cloned eDNA [J]. Nature, 1990, 346(6284): 561-564.
  • 7Reggio PH. Pharmaeophores for ligand recognition and activation/ inactivation of the eannabinoid receptors [ J ]. Curr Pharm Des, 2003, 9(20) : 1607-1633.
  • 8Martin BR, Sim-Selley LJ, Selley DE. Signaling pathways involved in the development of cannabinoid tolerance [ J ]. Trends Pharmacol Sci, 2004, 25(6) : 325-330.
  • 9Borrelli F, Izzo AA. Role of aeylethanolamides in the gastrointesti- nal tract with special reference to food intake and energy balance [J]. Best Praet Res Clin Endoerinol Metab, 2009, 23 ( 1 ) : 33- 49.
  • 10Bondarenko A, Waldeck-Weiermair M, Naghdi S, et al. GPR55- dependent and -independent ion signalling in response to lysophos phatidylinositol in endothelial ceils[ J]. Br J Pharmacol, 2010, 161(2) : 308-320.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部